2026 Q1 Portfolio Activity
In 2026 Q1, TANG CAPITAL MANAGEMENT LLC maintained a portfolio of 79 distinct positions. The most significant new addition was COMPASS PATHWAYS PLC, now representing 1.12% of the total fund value. They heavily accumulated shares in STATE STR SPDR S&P 500 ETF T, increasing the position by 460.0%. Conversely, TANG CAPITAL MANAGEMENT LLC completely exited their position in AVIDITY BIOSCIENCES INC.
Position History
hover any row below to update
Loading…
Total Positions
79
Quarter
2026 Q1
Top Holding
AUPH (9.2%)
Top 10 Concentration
57.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 79
TANG CAPITAL MANAGEMENT LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AUPH
AURINIA PHARMAC...
|
Healthcare | 9.20% | 8.93% |
#1
Prev: #1
|
7.7 |
—
|
900,000 | 7.9% |
P
S
|
12,229,500 | $181,241,190 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CELC
CELCUITY INC
|
Healthcare | 6.09% | 5.17% |
#2
2
Prev: #4
|
4.9 |
—
|
no change | no change |
P
S
|
1,050,000 | $119,847,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 5.80% | 4.82% |
#3
2
Prev: #5
|
4.3 |
—
|
no change | no change |
P
S
|
1,236,027 | $114,184,174 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GLPG
GALAPAGOS NV
|
Healthcare | 5.77% | 6.33% |
#4
2
Prev: #2
|
3.3 |
—
|
-135,228 | -3.4% |
P
S
|
3,785,991 | $113,579,730 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SPY
STATE STR SPDR ...
|
ETF | 5.55% | 1.01% |
#5
19
Prev: #24
|
5.7 |
—
|
138,000 | 460.0% |
P
S
|
168,000 | $109,257,120 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KNSA
KINIKSA PHARMAC...
|
Healthcare | 5.53% | 4.60% |
#6
1
Prev: #7
|
3.2 |
—
|
no change | no change |
P
S
|
2,259,889 | $108,813,655 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 5.25% | 2.42% |
#7
8
Prev: #15
|
5.1 |
—
|
1,699,900 | 100.0% |
P
S
|
3,399,900 | $103,356,960 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 5.19% | 5.63% |
#8
5
Prev: #3
|
3.1 |
—
|
no change | no change |
P
S
|
1,500,000 | $102,195,000 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 4.85% | 3.06% |
#9
4
Prev: #13
|
2.9 |
—
|
no change | no change |
P
S
|
1,892,200 | $95,442,568 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 4.68% | 3.65% |
#10
Prev: #10
|
2.9 |
—
|
no change | no change |
P
S
|
4,573,530 | $92,065,159 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 4.51% | 4.45% |
#11
2
Prev: #9
|
2.8 |
—
|
no change | no change |
P
S
|
16,790,809 | $88,823,380 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 4.23% | 4.81% |
#12
6
Prev: #6
|
2.7 |
—
|
no change | no change |
P
S
|
1,188,624 | $83,381,974 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 4.06% | 4.51% |
#13
5
Prev: #8
|
2.1 |
—
|
20,830 | 0.8% |
P
S
|
2,649,368 | $79,878,445 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANAB
ANAPTYSBIO INC
|
Healthcare | 3.75% | 3.19% |
#14
2
Prev: #12
|
2.0 |
—
|
-1,208 | -0.1% |
P
S
|
1,330,879 | $73,810,549 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CORT
CORCEPT THERAPE...
|
Healthcare | 3.07% | 0.27% |
#15
42
Prev: #57
|
4.2 |
—
|
1,343,236 | 856.9% |
P
S
|
1,500,000 | $60,465,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 2.76% | 1.88% |
#16
1
Prev: #17
|
3.6 |
—
|
226,063 | 47.0% |
P
S
|
707,500 | $54,406,750 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INSM
INSMED INC
|
Healthcare | 2.16% | 0.52% |
#17
21
Prev: #38
|
3.9 |
—
|
200,000 | 333.3% |
P
S
|
260,000 | $42,515,200 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BNTX
BIONTECH SE
|
Healthcare | 2.12% | 2.21% |
#18
2
Prev: #16
|
1.8 |
—
|
no change | no change |
P
S
|
470,000 | $41,773,600 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 1.78% | 2.76% |
#19
5
Prev: #14
|
1.7 |
—
|
no change | no change |
P
S
|
1,792,626 | $35,063,765 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVIR
ATEA PHARMACEUT...
|
Healthcare | 1.32% | 0.85% |
#20
7
Prev: #27
|
1.5 |
—
|
no change | no change |
P
S
|
4,814,700 | $25,903,086 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PGEN
PRECIGEN INC
|
Healthcare | 1.26% | 1.16% |
#21
2
Prev: #23
|
2.5 |
—
|
800,000 | 14.2% |
P
S
|
6,417,500 | $24,835,725 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.13% | 0.54% |
#22
13
Prev: #35
|
1.5 |
—
|
no change | no change |
P
S
|
264,692 | $22,212,953 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 1.12% | — |
#23
Prev: #—
|
3.9 |
—
|
4,002,200 | — |
NEW
|
4,002,200 | $22,132,166 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 1.08% | 0.51% |
#24
15
Prev: #39
|
2.9 |
—
|
287,602 | 33.0% |
P
S
|
1,160,000 | $21,309,200 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 0.83% | 0.78% |
#25
3
Prev: #28
|
1.3 |
—
|
no change | no change |
P
S
|
500,000 | $16,280,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.83% | 0.87% |
#26
Prev: #26
|
1.3 |
—
|
no change | no change |
P
S
|
500,000 | $16,270,000 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 0.76% | 0.77% |
#27
2
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
450,000 | $14,994,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 0.69% | 1.71% |
#28
9
Prev: #19
|
0.8 |
—
|
-707,900 | -18.4% |
P
S
|
3,149,557 | $13,511,600 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PLRX
PLIANT THERAPEU...
|
Healthcare | 0.39% | 0.37% |
#29
21
Prev: #50
|
1.2 |
—
|
no change | no change |
P
S
|
6,143,132 | $7,740,346 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DERM
JOURNEY MED COR...
|
Healthcare | 0.38% | 0.71% |
#30
2
Prev: #32
|
0.7 |
—
|
-244,596 | -13.2% |
P
S
|
1,610,000 | $7,550,900 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 0.35% | — |
#31
Prev: #—
|
3.6 |
—
|
500,000 | — |
NEW
|
500,000 | $6,950,000 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 0.33% | 0.30% |
#32
24
Prev: #56
|
1.1 |
—
|
no change | no change |
P
S
|
35,000 | $6,416,550 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 0.32% | 0.40% |
#33
12
Prev: #45
|
1.1 |
—
|
no change | no change |
P
S
|
350,000 | $6,293,000 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARVN
ARVINAS INC
|
Healthcare | 0.29% | 0.33% |
#34
17
Prev: #51
|
0.6 |
—
|
-31,040 | -5.4% |
P
S
|
538,658 | $5,709,775 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PMVP
PMV PHARMACEUTI...
|
Healthcare | 0.27% | 0.31% |
#35
19
Prev: #54
|
0.6 |
—
|
-694,915 | -14.1% |
P
S
|
4,245,085 | $5,263,905 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRNA
MODERNA INC
|
Healthcare | 0.26% | 1.01% |
#36
11
Prev: #25
|
0.1 |
—
|
-592,820 | -85.6% |
P
S
|
100,000 | $5,080,000 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HRTX
HERON THERAPEUT...
|
Healthcare | 0.25% | 0.40% |
#37
9
Prev: #46
|
1.1 |
—
|
no change | no change |
P
S
|
6,250,000 | $5,000,625 | 2014 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KZR
KEZAR LIFE SCIE...
|
Healthcare | 0.25% | 0.21% |
#38
22
Prev: #60
|
1.1 |
—
|
no change | no change |
P
S
|
664,314 | $4,929,210 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 0.22% | 0.50% |
#39
1
Prev: #40
|
1.1 |
—
|
no change | no change |
P
S
|
600,000 | $4,350,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LENZ
LENZ THERAPEUTI...
|
Healthcare | 0.21% | 0.68% |
#40
7
Prev: #33
|
0.1 |
—
|
-414,055 | -47.9% |
P
S
|
451,114 | $4,127,696 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.17% | — |
#41
Prev: #—
|
3.6 |
—
|
100,000 | — |
NEW
|
100,000 | $3,383,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ERAS
ERASCA INC
|
Healthcare | 0.16% | 0.17% |
#42
20
Prev: #62
|
0.1 |
—
|
-700,000 | -77.8% |
P
S
|
200,000 | $3,236,000 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CHRS
COHERUS ONCOLOG...
|
Healthcare | 0.16% | 0.19% |
#43
18
Prev: #61
|
0.1 |
—
|
-837,761 | -30.7% |
P
S
|
1,886,748 | $3,188,604 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NKTX
NKARTA INC
|
Healthcare | 0.16% | 0.14% |
#44
19
Prev: #63
|
1.1 |
—
|
no change | no change |
P
S
|
1,480,823 | $3,124,537 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALT
ALTIMMUNE INC
|
Healthcare | 0.10% | 0.38% |
#45
3
Prev: #48
|
0.0 |
—
|
-1,465,285 | -68.8% |
P
S
|
666,022 | $2,051,348 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 0.10% | 0.41% |
#46
3
Prev: #43
|
0.0 |
—
|
-762,671 | -61.2% |
P
S
|
483,021 | $1,985,216 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABEO
ABEONA THERAPEU...
|
Healthcare | 0.09% | 0.26% |
#47
11
Prev: #58
|
0.0 |
—
|
-600,000 | -60.0% |
P
S
|
400,000 | $1,792,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FATE
FATE THERAPEUTI...
|
Healthcare | 0.07% | 0.06% |
#48
22
Prev: #70
|
1.0 |
—
|
no change | no change |
P
S
|
1,167,773 | $1,401,328 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NMRA
NEUMORA THERAPE...
|
Healthcare | 0.04% | 0.09% |
#49
17
Prev: #66
|
0.0 |
—
|
-527,357 | -54.5% |
P
S
|
439,878 | $857,762 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LXRX
LEXICON PHARMAC...
|
Healthcare | 0.03% | — |
#50
Prev: #—
|
3.5 |
—
|
399,700 | — |
NEW
|
399,700 | $623,532 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 79 holdings